Dr. Claes Wahlestedt, MD, Ph.D. is the Consulting Chief Medical Officer and Co-Chairman of the Scientific Advisory Board at Jupiter Orphan Therapeutics. He is a native Swede, obtaining his MD and PhD degrees from Lund University. Dr. Wahlestedt is a renowned scientist throughout the pharmaceutical industry. He is presently the Leonard M. Miller Professor & Associate Dean for Therapeutic Innovation at the University of Miami Miller School of Medicine. Between 2005-2011 Dr. Wahlestedt was the founding professor and Director of Neuroscience at The Scripps Research Institute in Florida. Before that, Dr. Wahlestedt was the Professor and Department Chair at Karolinska Institute in Stockholm, Sweden from 1997-2005. He has previously been a faculty member at Cornell University Medical College as well as at McGill University. Dr. Wahlestedt has also spent more than a decade directing R&D teams for Astra-Zeneca and Pharmacia/Pfizer. Along with all of Dr. Wahlestedt's pharmaceutical ventures, he has also co-founded 3 biotech companies. Dr. Wahlestedt enjoys his off time on the golf course.